
How Quantum Computing Is Changing Drug Pricing
transcript
show notes
In this episode of Quantum Computing Business with Fexingo, Lucas and Luna explore how quantum computing is beginning to reshape the economics of drug pricing. They focus on a specific angle: using quantum algorithms to model the full cost structure of a drug's lifecycle, from R&D through manufacturing to market access. The conversation centers on a recent proof-of-concept from a mid-size biotech firm that used a quantum optimizer to reduce the cost of a specialty drug's supply chain by 12 percent, and what that could mean for the sticker price. They also discuss how quantum-powered 'value-based pricing' models could tie prices to real-world outcomes in ways traditional analytics can't. Lucas and Luna keep it grounded, avoiding hype, and connect the dots for business leaders. By the end, you'll understand why quantum pricing isn't about predicting markets—it's about building better cost models that could, over time, make drugs more affordable. This episode is a follow-up to earlier discussions on drug discovery, but it's a standalone angle on pricing, a topic rarely covered in the quantum business space.
#QuantumComputing #DrugPricing #PharmaEconomics #ValueBasedPricing #SupplyChainOptimization #HealthEconomics #QuantumOptimization #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #TechTrends #Biotech #LifeSciences #CostModeling #QuantumAlgorithms #HealthcareIndustry #DataDrivenPricing #Innovation
